Cited 2 times in 
Cited 2 times in 
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Jeong Su | - |
| dc.contributor.author | Bae, Soo Han | - |
| dc.date.accessioned | 2021-05-21T17:00:35Z | - |
| dc.date.available | 2021-05-21T17:00:35Z | - |
| dc.date.created | 2022-01-19 | - |
| dc.date.issued | 2020-10 | - |
| dc.identifier.issn | 2287-2728 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/182655 | - |
| dc.description.abstract | [NO ABSTRACT AVAILABLE] | - |
| dc.description.statementOfResponsibility | open | - |
| dc.language | English | - |
| dc.publisher | Korean Association for the Study of the Liver | - |
| dc.relation.isPartOf | Clinical and Molecular Hepatology | - |
| dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma? | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | BioMedical Science Institute (의생명과학부) | - |
| dc.contributor.googleauthor | Park, Jeong Su | - |
| dc.contributor.googleauthor | Bae, Soo Han | - |
| dc.identifier.doi | 10.3350/cmh.2020.0143 | - |
| dc.relation.journalcode | J00557 | - |
| dc.identifier.eissn | 2287-285X | - |
| dc.subject.keyword | Carcinoma | - |
| dc.subject.keyword | Hepatocellular | - |
| dc.subject.keyword | PI3K inhibitor | - |
| dc.subject.keyword | GSK3 beta | - |
| dc.subject.keyword | EMT | - |
| dc.contributor.alternativeName | Park, Jeong Su | - |
| dc.contributor.affiliatedAuthor | Park, Jeong Su | - |
| dc.contributor.affiliatedAuthor | Bae, Soo Han | - |
| dc.identifier.scopusid | 2-s2.0-85092785048 | - |
| dc.identifier.wosid | 000580510600019 | - |
| dc.citation.volume | 26 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 577 | - |
| dc.citation.endPage | 578 | - |
| dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, Vol.26(4) : 577-578, 2020-10 | - |
| dc.identifier.rimsid | 71965 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Carcinoma | - |
| dc.subject.keywordAuthor | Hepatocellular | - |
| dc.subject.keywordAuthor | PI3K inhibitor | - |
| dc.subject.keywordAuthor | GSK3 beta | - |
| dc.subject.keywordAuthor | EMT | - |
| dc.type.docType | Letter | - |
| dc.identifier.kciid | ART002633678 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.